Stay Updated with the Latest Brooks Automation, Inc. BRKS News in Real Time
Find BRKS news now at Meyka AI. Stay informed with the latest Brooks Automation, Inc. stocks updates, including price news, market analysis, and expert insights.
Liontrust (LON: LIO) Shares Jump 12% as Operating Margin Beats Forecast at 24%
Introduction Liontrust Asset Management (LON: LIO) delivered one of its strongest single-session moves in years on June 24, 2026. Liontrust stock surged 12.4% to reach 330.4p after the independent fund manager published its annual results for the financial year ended March 31, 2026, delivering an adjusted operating margin of 24% ahead of the analyst consensus…
Meta Cuts 8,000 Jobs After Record $56.3B Quarter and $921M Executive Options
Meta entered 2026 with strong momentum. The company reported a record $56.3 billion in quarterly revenue and billions in profit, showing the strength of its advertising business. Yet, in a surprising move, Meta announced plans to cut around 8,000 jobs while increasing its focus on artificial intelligence. The decision has drawn even more attention because…
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Oracle Cuts 21,000 Jobs as Workforce Falls to 141,000, AI-Driven Restructuring Trims 13% of Staff
Oracle’s workforce dropped to 141,000 employees in fiscal 2026 after the company reduced its headcount by about 21,000 workers, a decline of roughly 13%. The move comes as Oracle accelerates its investment in artificial intelligence, cloud services, and large-scale data centers. Announced in June 2026, the restructuring reflects a growing trend across the tech industry,…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…